Flash Finance

Vasa Denticity LimitedDENTALKARTCorporate

Medical Equipment & Supplies Latest results: Jun 2026 12 quarters of data
Consolidated Standalone
₹444.00
MCap ₹770 Cr · P/E 66.9
Vasa Denticity Limited — Stock analysis & AI research Vasa Denticity Limited — Seasonality — best & worst months Vasa Denticity Limited — Live exchange announcements
📋 High Interest Coverage Stocks📋 Debt Free Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹83 Cr
Sales · Jun 2026
+13.9% YoY
₹5 Cr
Operating Profit · Jun 2026
-20.7% YoY
6.1%
OPM % · Jun 2026
-29.9% YoY
₹4 Cr
Net Profit · Jun 2026
-2.3% YoY
₹2.36
EPS · Jun 2026
-7.1% YoY

📝 Vasa Denticity Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Vasa Denticity Limited reported revenue of ₹83 crore for the quarter ended June 2026 (Q1 FY27), up 13.9% from ₹73 crore in the same quarter last year, and up 13.5% sequentially over the March 2026 quarter.

Net profit fell 2.3% year-on-year to ₹4 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹2.36.

Operating profit stood at ₹5 crore — an operating margin (OPM) of 6.1%, compared with 8.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Vasa Denticity Limited posted revenue of ₹291 crore, a growth of 17.4% over FY25, with a net profit of ₹12 crore (down 31.3% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹301 crore with a net profit of ₹12 crore.

Valuation snapshot

At the current price of ₹444.00, DENTALKART has a market capitalisation of ₹770 crore and a trailing P/E of about 66.9.

Within the Medical Equipment & Supplies industry, it is the 3rd-largest of the 13 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 60.19%, foreign institutional investors (FIIs) 6.93%, domestic institutional investors (DIIs) 1.66%, public shareholders 31.23% of Vasa Denticity Limited.

Promoter holding slipped from 60.75% to 60.19% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹770 Cr
Current Price ?
₹444.0
P/E ?
66.88above ind
Industry P/E ?
26.90
P/B ?
4.43
P/S ?
2.55
P/FCF ?
-24.84
Enterprise Value ?
₹770 Cr
EV/EBITDA ?
59.54
PEG ?
N/A
Earnings Yield ?
1.3%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹301 Cr
OPM ?
4.3%
Profit after tax (TTM) ?
₹12 Cr
EPS (TTM) ?
₹6.64
ROCE ?
9.0%
ROE ?
6.6%
ROA ?
5.8%
Growth
Sales — latest qtr ?
₹83 Cr
PAT — latest qtr ?
₹4 Cr
YoY qtr sales growth ?
13.9%
YoY qtr profit growth ?
-2.3%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
92.2
Current Ratio ?
N/A
Ownership
Promoter holding ?
60.19%
Change in promoter holding ?
-5.78%
Pledged percentage ?
N/A
Market
Return 3 months ?
2.7%
Return 6 months ?
16.2%

🗓️ Quarterly results (12 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 773795545863737373727383 +13.9% +13.5%
Operating Profit 7312566666205 -20.7% +1708.7%
Other Income 100010001121 +378.2% -55.0%
Interest 000000000000 -11.5% -61.5%
Depreciation 001000110111 +37.4% +15.4%
Profit Before Tax 8312575666225 -13.6% +222.9%
Net Profit 629354445114 -2.3% +229.3%
EPS 4.191.525.532.123.352.392.532.542.830.790.772.36 -7.1% +206.5%
OPM % 8.9% 9.4% 12.9% 8.5% 11.0% 8.8% 8.8% 8.7% 8.0% 2.4% 0.4% 6.1% -29.9% +1425.0%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹248 Cr ₹291 Cr ₹301 Cr +17.4%
Operating Profit ₹23 Cr ₹14 Cr ₹13 Cr -37.8%
OPM % 9.24% 4.89% 4.29% -47.1%
NPM % 6.80% 3.98% 3.82% -41.5%
Other Income ₹2 Cr ₹4 Cr ₹4 Cr +94.1%
Depreciation ₹2 Cr ₹2 Cr ₹3 Cr +36.6%
Interest ₹0 Cr ₹0 Cr ₹0 Cr +1128.6%
EBIT ₹21 Cr ₹12 Cr ₹10 Cr -43.9%
PBT ₹23 Cr ₹16 Cr ₹15 Cr -32.9%
Tax ₹3 Cr ₹4 Cr ₹3 Cr +30.8%
Net Profit ₹17 Cr ₹12 Cr ₹12 Cr -31.3%
EPS ₹10.39 ₹6.93 ₹6.75 -33.3%
Material Cost ₹104 Cr ₹158 Cr ₹186 Cr +52.1%
Employee Cost ₹6 Cr ₹16 Cr ₹18 Cr +169.3%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 3 periods)

Metric Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 161717 +0.0%
Reserves 52116157 +35.3%
Borrowings 000 —
Other Liabilities 171923 +21.1%
Total Liabilities 86151197 +30.5%
Fixed Assets 21625 +56.2%
CWIP 161 -83.3%
Investments 124242 +0.0%
Other Assets 7087129 +48.3%
Total Assets 86151197 +30.5%

💧 Cash Flow (latest 3 periods)

Metric Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -11-4-25 -525.0%
Cash from Investing Activity -22-43-4 +90.7%
Cash from Financing Activity 364730 -36.2%
Net Cash Flow 310 -100.0%
Free Cash Flow -14-24-31 -29.2%
CFO/OP -35%11%-197% -1890.9%

➗ Ratios (latest 3 periods)

Metric Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 242116 -23.8%
Inventory Days 99112151 +34.8%
Days Payable 332326 +13.0%
Cash Conversion Cycle 90110141 +28.2%
Working Capital Days 8495185 +94.7%
ROCE % —22%9% -59.1%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 65.97%66.00%60.75%60.19% -0.9%
FIIs 3.53%4.00%7.50%6.93% -7.6%
DIIs 1.77%1.00%0.87%1.66% +90.8%
Public 28.73%30.00%30.88%31.23% +1.1%
No. of Shareholders 3,1133,0542,9462,495 -15.3%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 FISCHER Fischer Medical ₹33.50 2,293 85.2 367 24 12.3% 6.7% 178.6% 2051.4% 249.4% -24.3%
2 TARSONS Tarsons Products ₹330.00 1,756 157.9 441 11 27.0% 2.5% -66.3% -81.4% 20.7% -181.0%
3 DENTALKART Vasa Denticity ₹563.10 977 80.0 299 12 4.4% 4.0% 16.7% -28.5% 12.9% -2.9%
4 543916 Hemant Surgical ₹193.85 544 13.9 231 18 10.4% 7.8% — — 187.9% 160.0%
5 543363 Prevest Denpro ₹616.50 456 32.8 75 23 35.7% 29.9% 13.6% 17.6% 23.7% 24.8%
6 QMSMEDI QMS Medical ₹185.89 359 52.7 162 7 13.1% 4.1% 5.1% -47.9% 23.7% -0.8%
7 NURECA Nureca ₹331.55 331 75.9 153 4 2.7% 2.8% 34.0% 146.7% 18.0% 277.2%
8 530427 Choksi Asia ₹65.64 122 7.2 47 5 14.5% 11.1% 61.1% 173.2% -22.5% -10.1%
9 527005 Shree Pacetronix ₹168.25 55 19.2 21 3 24.8% 15.3% 28.7% 324.3% -8.3% 14.5%
10 544143 Royal Sense ₹139.00 47 24.7 38 3 12.8% 8.0% — — 2.5% -5.4%
11 533212 GKB Ophthalmics ₹104.90 32 17.6 150 6 7.0% 3.7% 36.8% 142.7% 2.3% 388.5%
12 531380 Centenial Surgical ₹110.90 27 — 56 -1 10.7% -2.6% 0.6% -38.1% 18.6% 1937.8%
13 542765 Transpact Enterprises ₹325.00 4 140.1 0 0 63.2% 47.4% — — 12.5% -20.0%
❓ Frequently asked questions
What was Vasa Denticity Limited's revenue in Q1 FY27?
Vasa Denticity Limited reported revenue of ₹83 crore for the quarter ended June 2026 (Q1 FY27), up 13.9% from ₹73 crore in the same quarter last year, and up 13.5% sequentially over the March 2026 quarter.
What was Vasa Denticity Limited's net profit in Q1 FY27?
Net profit fell 2.3% year-on-year to ₹4 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹2.36.
What is DENTALKART's market capitalisation and P/E ratio?
At the current price of ₹444.00, DENTALKART has a market capitalisation of ₹770 crore and a trailing P/E of about 66.9.
Who owns Vasa Denticity Limited? (shareholding pattern)
As of Mar 2026, promoters held 60.19%, foreign institutional investors (FIIs) 6.93%, domestic institutional investors (DIIs) 1.66%, public shareholders 31.23% of Vasa Denticity Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI